Repeated Administration of High Dose Depot Medroxy Progesterone Acetate does not Alter SHIVSF162p3 Viral Kinetics and Tenofovir Pharmacokinetics when Delivered via Intravaginal Rings
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Repeated Administration of High Dose Depot Medroxy Progesterone Acetate does not Alter SHIVSF162p3 Viral Kinetics and Tenofovir Pharmacokinetics when Delivered via Intravaginal Rings
  • Published Date:

    August 2017

  • Source:
    J Med Primatol. 46(4):129-136
  • Language:
    English
Filetype[PDF-510.23 KB]


Details:
No Related Documents.

You May Also Like: